EPISODE · Jun 1, 2026 · 15 MIN
Dis‑Chem's FY2026 Mixed as Revenue Climbs, Earnings Dip
from Kaya 959 · host Gugulethu Mfuphi
Dis‑Chem CEO Rui Morais unpacks a results set showing strong revenue growth but pressure on headline earnings. He explains the Group’s R445m investment into its healthcare ecosystem, the performance of Better Rewards, margin pressure in dispensary and wholesale, and how the Store of the Future will reshape customer experience and profitability. Kaya FM
Embed this episode
NOW PLAYING
Dis‑Chem's FY2026 Mixed as Revenue Climbs, Earnings Dip
No transcript for this episode yet
Similar Episodes
No similar episodes found.
Similar Podcasts
No similar podcasts found.